The potential of nanocomposites (patuletin-conjugated with gallic acid-coated zinc oxide) against free-living amoebae pathogens
International Microbiology · 2024
DOI: 10.1007/s10123-024-00584-w ↗Kurz gefasst
Fachartikel in der Zeitschrift International Microbiology, 2024. Verfasst von Ruqaiyyah Siddiqui und 7 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Biological Chemistry, Biophysics and Bioengineering, Heriot-Watt University, Edinburgh, EH14 4AS, UK. Hauptthemen laut MEDLINE: Zinc Oxide, Gallic Acid, Nanocomposites, Amebicides. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 56 Literaturangaben. Gefördert von: Taif University, Air Force Office of Scientific Research.
Abstract (Originalsprache)
Free-living amoebae infections are on the rise while the prognosis remains poor. Current therapies are ineffective, and there is a need for novel effective drugs which can target Naegleria, Balamuthia, and Acanthamoeba species. In this study, we determined the effects of a nano-formulation based on flavonoid patuletin-loaded gallic acid functionalized zinc oxide nanoparticles (PA-GA-ZnO) against Acanthamoeba, Balamuthia, and Naegleria trophozoites. Characterization of the nano-formulation was accomplished utilizing analytical tools, namely Fourier-transform infrared spectroscopy, drug entrapment efficiency, polydispersity index, dimensions, and surface morphologies. Anti-amoebic effects were investigated using amoebicidal assay, cytopathogenicity assay, and cytotoxicity of the nano-formulation on human cells. The findings revealed that nano-formulation (PA-GA-ZnO) displayed significant anti-amoebic properties and augmented effects of patuletin alone against all three brain-eating amoebae. When tested alone, patuletin nano-formulations showed minimal toxicity effects against human cells. In summary, the nano-formulations evaluated herein depicts efficacy versus Acanthamoeba, Balamuthia, and Naegleria. Nonetheless, future studies are needed to comprehend the molecular mechanisms of patuletin nano-formulations versus free-living amoebae pathogens, in addition to animal studies to determine their potential value for clinical applications.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Biological Chemistry, Biophysics and Bioengineering, Heriot-Watt University, Edinburgh, EH14 4AS, UK.
- Microbiota Research Center, Istinye University, Istanbul, 34010, Turkey.
- International Center for Chemical and Biological Sciences, H.E.J. Research Institute of Chemistry, University of Karachi, Karachi, 75270, Pakistan.
- Research Institute of Medical and Health Sciences, University of Sharjah, 27272, Sharjah, United Arab Emirates.
- Department of Clinical Laboratories Sciences, College of Applied Medical Sciences, Taif University, P.O. Box 11099, 21944, Taif, Saudi Arabia.
- Microbiota Research Center, Istinye University, Istanbul, 34010, Turkey. naveed5438@gmail.com.
Förderung
- Taif University
- Air Force Office of Scientific Research
Zitieren
APA
Siddiqui, R., Khatoon, B., Kawish, M., Sajeev, S., Faizi, S., Shah, M. R., Alharbi, A. M., & Khan, N. A. (2024). The potential of nanocomposites (patuletin-conjugated with gallic acid-coated zinc oxide) against free-living amoebae pathogens. International Microbiology. https://doi.org/10.1007/s10123-024-00584-w
Vancouver
Siddiqui R, Khatoon B, Kawish M, Sajeev S, Faizi S, Shah MR, et al. The potential of nanocomposites (patuletin-conjugated with gallic acid-coated zinc oxide) against free-living amoebae pathogens. International Microbiology. 2024. doi:10.1007/s10123-024-00584-w
BibTeX
@article{Siddiqui2024,
author = {Siddiqui, Ruqaiyyah and Khatoon, Bushra and Kawish, Muhammad and Sajeev, Sreedevi and Faizi, Shaheen and Shah, Muhammad Raza and Alharbi, Ahmad M and Khan, Naveed Ahmed},
title = {The potential of nanocomposites (patuletin-conjugated with gallic acid-coated zinc oxide) against free-living amoebae pathogens},
journal = {International Microbiology},
year = {2024},
doi = {10.1007/s10123-024-00584-w}
}
EUVIMED